Medtronic Revenue 2012-2026 | MDT
Medtronic annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Medtronic revenue for the quarter ending July 31, 2026 was $9.756B, a 13.73% increase year-over-year.
- Medtronic revenue for the twelve months ending July 31, 2026 was $37.542B, a 9.77% increase year-over-year.
- Medtronic annual revenue for 2026 was $36.364B, a 8.43% increase from 2025.
- Medtronic annual revenue for 2025 was $33.537B, a 3.62% increase from 2024.
- Medtronic annual revenue for 2024 was $32.364B, a 3.64% increase from 2023.
|
Medtronic Annual Revenue (Millions of US $) |
|
|---|---|
| 2026 | $36,364 |
| 2025 | $33,537 |
| 2024 | $32,364 |
| 2023 | $31,227 |
| 2022 | $31,686 |
| 2021 | $30,117 |
| 2020 | $28,913 |
| 2019 | $30,557 |
| 2018 | $29,953 |
| 2017 | $29,710 |
| 2016 | $28,833 |
| 2015 | $20,261 |
| 2014 | $17,005 |
| 2013 | $16,590 |
| 2012 | $16,184 |
|
Medtronic Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2026-07-31 | $9,756 |
| 2026-04-30 | $9,808 |
| 2026-01-31 | $9,017 |
| 2025-10-31 | $8,961 |
| 2025-07-31 | $8,578 |
| 2025-04-30 | $8,927 |
| 2025-01-31 | $8,292 |
| 2024-10-31 | $8,403 |
| 2024-07-31 | $7,915 |
| 2024-04-30 | $8,589 |
| 2024-01-31 | $8,089 |
| 2023-10-31 | $7,984 |
| 2023-07-31 | $7,702 |
| 2023-04-30 | $8,544 |
| 2023-01-31 | $7,727 |
| 2022-10-31 | $7,585 |
| 2022-07-31 | $7,371 |
| 2022-04-30 | $8,089 |
| 2022-01-31 | $7,763 |
| 2021-10-31 | $7,847 |
| 2021-07-31 | $7,987 |
| 2021-04-30 | $8,188 |
| 2021-01-31 | $7,775 |
| 2020-10-31 | $7,647 |
| 2020-07-31 | $6,507 |
| 2020-04-30 | $5,997 |
| 2020-01-31 | $7,717 |
| 2019-10-31 | $7,706 |
| 2019-07-31 | $7,493 |
| 2019-04-30 | $8,146 |
| 2019-01-31 | $7,546 |
| 2018-10-31 | $7,481 |
| 2018-07-31 | $7,384 |
| 2018-04-30 | $8,144 |
| 2018-01-31 | $7,369 |
| 2017-10-31 | $7,050 |
| 2017-07-31 | $7,390 |
| 2017-04-30 | $7,916 |
| 2017-01-31 | $7,283 |
| 2016-10-31 | $7,345 |
| 2016-07-31 | $7,166 |
| 2016-04-30 | $7,567 |
| 2016-01-31 | $6,934 |
| 2015-10-31 | $7,058 |
| 2015-07-31 | $7,274 |
| 2015-04-30 | $7,304 |
| 2015-01-31 | $4,318 |
| 2014-10-31 | $4,366 |
| 2014-07-31 | $4,273 |
| 2014-04-30 | $4,565 |
| 2014-01-31 | $4,163 |
| 2013-10-31 | $4,194 |
| 2013-07-31 | $4,083 |
| 2013-04-30 | $4,460 |
| 2013-01-31 | $4,027 |
| 2012-10-31 | $4,095 |
| 2012-07-31 | $4,008 |
| 2012-04-30 | $4,297 |
| 2012-01-31 | $3,918 |
| 2011-10-31 | $4,023 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $117.847B | $36.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $177.555B | 19.51 |
| Stryker (SYK) | United States | $105.529B | 19.72 |
| EssilorLuxottica (ESLOY) | France | $73.880B | 0.00 |
| Boston Scientific (BSX) | United States | $62.810B | 13.50 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.597B | 0.00 |
| Agilent Technologies (A) | United States | $44.113B | 25.82 |
| Medline (MDLN) | United States | $41.597B | 0.00 |
| ResMed (RMD) | United States | $32.455B | 20.14 |
| GE HealthCare Technologies (GEHC) | United States | $28.967B | 13.85 |
| Koninklijke Philips (PHG) | Netherlands | $24.258B | 12.92 |
| Terumo (TRUMY) | Japan | $20.887B | 19.94 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.189B | 11.25 |
| Baxter (BAX) | United States | $11.788B | 11.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.573B | 0.00 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.064B | 40.56 |
| Insulet (PODD) | United States | $9.751B | 23.95 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.563B | 20.19 |
| Raia Drogasil SA - (RADLY) | Brazil | $5.024B | 0.00 |
| BillionToOne (BLLN) | United States | $4.998B | 151.31 |
| Haemonetics (HAE) | United States | $4.932B | 21.64 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| ICU Medical (ICUI) | United States | $3.815B | 22.78 |
| Envista Holdings (NVST) | United States | $3.750B | 15.88 |
| AtriCure (ATRC) | United States | $2.955B | 252.61 |
| Neogen (NEOG) | United States | $2.835B | 50.00 |
| Curaleaf Holdings (CURLF) | United States | $2.445B | 0.00 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.265B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.132B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.130B | 10.17 |
| Perrigo (PRGO) | Ireland | $1.882B | 5.42 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.810B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.804B | 29.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.795B | 229.31 |
| Kestra Medical Technologies (KMTS) | United States | $1.455B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.426B | 15.21 |
| Phibro Animal Health (PAHC) | United States | $1.403B | 10.77 |
| Omeros (OMER) | United States | $1.294B | 6.55 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.065B | 0.00 |
| CeriBell (CBLL) | United States | $0.935B | 0.00 |
| InMode (INMD) | Israel | $0.825B | 11.48 |
| AdaptHealth (AHCO) | United States | $0.779B | 16.31 |
| VAREX IMAGING (VREX) | United States | $0.778B | 17.12 |
| Glass House Brands (GLAS) | United States | $0.748B | 0.00 |
| QuidelOrtho (QDEL) | United States | $0.728B | 7.87 |
| Valneva SE (VALN) | France | $0.622B | 0.00 |
| Brainsway (BWAY) | Israel | $0.547B | 30.93 |
| Tilray Brands (TLRY) | Canada | $0.543B | 0.00 |
| Cerus (CERS) | United States | $0.534B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.527B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.521B | 0.00 |
| Evolus (EOLS) | United States | $0.519B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.443B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.420B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.377B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.339B | 24.75 |
| Sanara MedTech (SMTI) | United States | $0.322B | 159.41 |
| TriSalus Life Sciences (TLSI) | United States | $0.314B | 0.00 |
| MacroGenics (MGNX) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.251B | 13.34 |
| OraSure Technologies (OSUR) | United States | $0.246B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.235B | 22.55 |
| High Tide (HITI) | Canada | $0.230B | 51.60 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Exagen (XGN) | United States | $0.204B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.202B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.197B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.156B | 0.00 |
| Organigram Global (OGI) | Canada | $0.148B | 0.00 |
| Quanterix (QTRX) | United States | $0.145B | 0.00 |
| Apyx Medical (APYX) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.090B | 124.38 |
| FitLife Brands (FTLF) | United States | $0.088B | 11.51 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.068B | 3.87 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.049B | 4.00 |
| Nephros (NEPH) | United States | $0.047B | 39.18 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.039B | 18.96 |
| United-Guardian (UG) | United States | $0.033B | 13.35 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.023B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.001B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |